Rockline Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Sell
49,547
-781
-2% -$91.4K 1.22% 25
2026
Q1
$6.05M Sell
50,328
-632
-1% -$73K 1.32% 20
2025
Q4
$5.36M Sell
50,960
-3,973
-7% -$373K 1.09% 26
2025
Q3
$4.61M Sell
54,933
-298
-0.5% -$24.5K 0.95% 30
2025
Q2
$4.37M Sell
55,231
-1,626
-3% -$129K 1.03% 29
2025
Q1
$5.1M Buy
56,857
+963
+2% +$89.9K 1.42% 20
2024
Q4
$5.56M Buy
55,894
+2,612
+5% +$269K 1.49% 16
2024
Q3
$6.05M Buy
53,282
+1,692
+3% +$201K 1.71% 12
2024
Q2
$6.39M Buy
51,590
+5,167
+11% +$666K 1.97% 9
2024
Q1
$6.13M Buy
46,423
+646
+1% +$79.6K 2.14% 6
2023
Q4
$4.99M Buy
+45,777
New +$4.75M 2.07% 9

Other funds holding MRK

Rockline Wealth Management's MRK Position: Q2 2026 in Review

Rockline Wealth Management reduced its Merck (MRK) stake by 1.6% in Q2 2026, selling an estimated $91.4K and leaving 49,547 shares worth $6.37M. The position accounts for 1.22% of the portfolio, ranked #25.

Rockline Wealth Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.39M in Q2 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rockline Wealth Management held 49,547 shares of Merck worth $6.37M as of Q2 2026.
  • Rockline Wealth Management sold 781 Merck shares in Q2 2026, an estimated $91.4K.
  • Merck made up 1.22% of Rockline Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Rockline Wealth Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Rockline Wealth Management's Merck position peaked at $6.39M in Q2 2024.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rockline Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.